Regulatory Ramblings: Episode 51 - The EU AI Act: Why it Matters for Asia and Beyond with Michael Borrelli (AI & Partners) and Anandaday Misshra (AMLEGALS)
Episode 85: Noel Ng | Goodwins Law Corporation
GILTI Conscience Podcast | Pillar Two Analysis: An Asia Pacific Viewpoint
Recent Developments in the South East Asia Renewables Market
Nota Bene Episode 105: Asia Q4 Check In: Asia Continues Marching Forward Post-Pandemic with Paul Kim
Nota Bene Episode 88: Asia Check In: COVID Recovery, China’s National Security Law for Hong Kong, and Navigating a U.S.-China Cold War with Paul Kim
Nota Bene Episode 69: Asia Check In: The Coronavirus’s Impact on Business, the Trilateral Summit, and Japan’s Criminal Justice System with Paul Kim
Dr. Frederick Ch’en discusses generic drugs and the changing pharmaceutical landscape in Asia
How Leading Philippine Companies are Using Bonds to Their Advantage
A Conversation with Lindsay Chu on Asia Restructurings
A Conversation with John Houghton on Asia Restructurings
A Conversation with Rajiv Gupta on Asia Restructurings
A Conversation with Ben Simpfendorfer on Asia Restructurings
A Conversation with David Heller on Asia Restructurings
A Conversation with Robyn Meredith on Asia Restructurings
Maximizing Outcomes in Upcoming Asia Restructurings - Executive Summary
Polsinelli Podcast - Conducting Business in China
Rapid digitalization in the health industry is set to drive M&A across the region - Digitalization is reshaping the global healthcare industry as demand for personalized, more accessible care fuels innovative market...more
Welcome to the August 2020 issue of our Life Sciences International Review. This issue covers new developments within Asia, Europe, and the United States in intellectual property, regulatory, pricing, and international trade,...more
Innovation in the life sciences and health care industries is occurring at a dizzying pace. Five years ago, anti-PD-1 antibodies from Merck and BMS had yet to be approved, CAR-T therapies were still in small-scale clinical...more